🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hong Zhao

Xiamen University

ORCID: 0000-0002-5515-6139

Also affiliated with Lanzhou University of Technology, Lanzhou University

Computer ScienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

5in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma.

60 citations

Paz J. Vellanki, Erin Larkins, Somak Chatterjee, Pallavi S. Mishra-Kalyani, Youwei Bi +11 more

22 citations

Yongchen Xu, Hong Zhao, Hong Sui, Hongyan Liang, Xiaofeng Jiang +1 more

18 citations

Jason D. Goldman, Hong Zhao, Alec Pankow, Fred Okuku, Michael Schmitt +6 more

11 citations

Xiang Ju, Hong Zhao, Zhi You, Run Han, Zhen Luo +1 more

2 citations

Zi-Qing Yu, Yi-Zhou Zhang, Yi-Qiao Deng, Xiao Chen, Hua-Yuan Liu +3 more

N/A
0.104DataRank · unranked
1 citations

Sha Zhang, Xia Liu, Hong Zhao, Hanxi Li

1 citations

Yueming Chen, Min Mao, Jun Yang, Jing Chang, Hong Zhao

N/A
0DataRank · unranked
36 citations

Hong Zhao, Stephen T.C. Wong, Yunjie He